Intuitive Surgical (NASDAQ:ISRG) Price Target Raised to $653.00

Intuitive Surgical (NASDAQ:ISRG) had its price target hoisted by HSBC from $644.00 to $653.00 in a research note issued to investors on Monday,MarketScreener reports. HSBC currently has a buy rating on the medical equipment provider’s stock.

Several other equities research analysts have also weighed in on the stock. Wall Street Zen upgraded shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Saturday, January 17th. Sanford C. Bernstein increased their price target on Intuitive Surgical from $740.00 to $750.00 and gave the stock an “outperform” rating in a research report on Friday, January 23rd. Leerink Partners raised their price target on Intuitive Surgical from $593.00 to $600.00 and gave the stock an “outperform” rating in a report on Wednesday, October 22nd. Rothschild & Co Redburn upped their price objective on Intuitive Surgical from $610.00 to $615.00 and gave the stock a “buy” rating in a research note on Thursday, October 23rd. Finally, Citigroup reiterated a “neutral” rating and issued a $590.00 target price (down from $635.00) on shares of Intuitive Surgical in a research note on Friday, January 23rd. Two equities research analysts have rated the stock with a Strong Buy rating, fourteen have issued a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $620.41.

Intuitive Surgical Trading Down 0.6%

ISRG stock opened at $522.04 on Monday. The stock’s 50 day simple moving average is $560.68 and its 200 day simple moving average is $511.75. Intuitive Surgical has a 12-month low of $425.00 and a 12-month high of $609.08. The firm has a market cap of $187.14 billion, a P/E ratio of 66.16, a P/E/G ratio of 4.27 and a beta of 1.67.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share for the quarter, beating the consensus estimate of $2.27 by $0.26. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. The firm had revenue of $2.87 billion during the quarter, compared to analyst estimates of $2.72 billion. During the same quarter in the previous year, the firm earned $2.21 earnings per share. The firm’s revenue for the quarter was up 18.8% compared to the same quarter last year. On average, research analysts forecast that Intuitive Surgical will post 6.43 EPS for the current fiscal year.

Insider Buying and Selling at Intuitive Surgical

In other news, SVP Mark Brosius sold 464 shares of the company’s stock in a transaction that occurred on Monday, December 15th. The shares were sold at an average price of $548.49, for a total value of $254,499.36. Following the completion of the sale, the senior vice president directly owned 131 shares of the company’s stock, valued at approximately $71,852.19. This represents a 77.98% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Gary S. Guthart sold 24,500 shares of the firm’s stock in a transaction that occurred on Tuesday, January 27th. The shares were sold at an average price of $530.10, for a total transaction of $12,987,450.00. Following the transaction, the director owned 3,694 shares in the company, valued at $1,958,189.40. This represents a 86.90% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders sold 75,557 shares of company stock valued at $42,000,903. 0.70% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Intuitive Surgical

A number of institutional investors and hedge funds have recently added to or reduced their stakes in ISRG. Riversedge Advisors LLC grew its holdings in Intuitive Surgical by 1.9% during the fourth quarter. Riversedge Advisors LLC now owns 901 shares of the medical equipment provider’s stock worth $510,000 after acquiring an additional 17 shares during the period. Fiduciary Financial Group LLC raised its holdings in shares of Intuitive Surgical by 2.1% in the 4th quarter. Fiduciary Financial Group LLC now owns 920 shares of the medical equipment provider’s stock worth $521,000 after purchasing an additional 19 shares in the last quarter. Prosperity Consulting Group LLC lifted its stake in Intuitive Surgical by 0.5% during the third quarter. Prosperity Consulting Group LLC now owns 4,033 shares of the medical equipment provider’s stock valued at $1,804,000 after purchasing an additional 19 shares during the last quarter. Rossmore Private Capital boosted its holdings in Intuitive Surgical by 2.0% during the third quarter. Rossmore Private Capital now owns 998 shares of the medical equipment provider’s stock worth $446,000 after buying an additional 20 shares in the last quarter. Finally, Activest Wealth Management increased its holdings in shares of Intuitive Surgical by 21.7% in the third quarter. Activest Wealth Management now owns 112 shares of the medical equipment provider’s stock valued at $50,000 after buying an additional 20 shares in the last quarter. 83.64% of the stock is owned by institutional investors.

More Intuitive Surgical News

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: FDA clears the da Vinci 5 system for select advanced cardiac procedures, widening the platform’s addressable market in minimally invasive heart surgery and supporting long‑term procedure growth. Read More.
• Positive Sentiment: TD Cowen initiated coverage with a “strong‑buy” rating, adding fresh analyst endorsement that can attract demand from institutional and retail buyers. Read More.
• Positive Sentiment: Barclays reaffirmed a buy stance on ISRG, maintaining additional sell‑side support. Read More.
• Positive Sentiment: HSBC published a bullish forecast calling for strong price appreciation, another vote of confidence from major bank research. Read More.
• Positive Sentiment: Polen Capital highlighted ISRG as a core holding in a growth strategy, indicating continued conviction from active growth managers. Read More.
• Neutral Sentiment: Coverage piece asks whether it’s time to reassess ISRG after recent share‑price weakness — useful for investors considering valuation or momentum shifts but not a direct catalyst. Read More.
• Negative Sentiment: Significant insider selling: Director Gary S. Guthart reported large sales (24,500 shares and an additional 2,800‑share sale across filings), substantially reducing his holdings — a short‑term headwind and common trigger for profit‑taking. Read More.
• Negative Sentiment: EVP Myriam Curet disclosed a smaller sale (230 shares). While modest, the sale adds to the day’s insider activity that may amplify negative sentiment. Read More.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.